Further, since insulin resistance is an early process of metabolic syndrome, we also examined markers of insulin resistance (fasting serum levels of glucose and insulin, derived β-cell function (HOMA2-%β), and homeostasis insulin resistance (HOMA2-%R)) with biliary tract cancer and stone risk in the same population. Here, INS is linked to biliary tract cancer.